| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7105207ca740add5aa1300e0c7f20a8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_526b7120bc3c9574e53eb469568c1ff3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 |
| filingDate |
2001-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e59d49d912fa83355f51db922ee91c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93ae484ddc1a6d21268ca423088f19a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eadc411fb81e9829205d8419834e9ca |
| publicationDate |
2002-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0207726-A2 |
| titleOfInvention |
Treatment of movement disorders |
| abstract |
The present invention relates to the use of compounds which inhibit D5-dopamine receptors, such as D5-dopamine receptor antagonists, for the treatment of movement disorders associated with a poverty of movement and more particularly for the treatment of parkinsonism (e.g. Parkison's disease). |
| priorityDate |
2000-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |